Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11068592rdf:typepubmed:Citationlld:pubmed
pubmed-article:11068592lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:11068592lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:11068592lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11068592lifeskim:mentionsumls-concept:C0278627lld:lifeskim
pubmed-article:11068592lifeskim:mentionsumls-concept:C0040223lld:lifeskim
pubmed-article:11068592lifeskim:mentionsumls-concept:C0040225lld:lifeskim
pubmed-article:11068592pubmed:issue10lld:pubmed
pubmed-article:11068592pubmed:dateCreated2000-11-16lld:pubmed
pubmed-article:11068592pubmed:abstractTextThe treatment of malignant tumors consists in the optimal combination of the 4 modalities surgery, radiotherapy, chemotherapy, and immunotherapy. An important goal of clinical research is the development of the optimal application of each of these modalities.lld:pubmed
pubmed-article:11068592pubmed:languagegerlld:pubmed
pubmed-article:11068592pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11068592pubmed:citationSubsetIMlld:pubmed
pubmed-article:11068592pubmed:statusMEDLINElld:pubmed
pubmed-article:11068592pubmed:monthOctlld:pubmed
pubmed-article:11068592pubmed:issn0179-7158lld:pubmed
pubmed-article:11068592pubmed:authorpubmed-author:PfreundschuhM...lld:pubmed
pubmed-article:11068592pubmed:authorpubmed-author:TrümperLLlld:pubmed
pubmed-article:11068592pubmed:issnTypePrintlld:pubmed
pubmed-article:11068592pubmed:volume176lld:pubmed
pubmed-article:11068592pubmed:ownerNLMlld:pubmed
pubmed-article:11068592pubmed:authorsCompleteYlld:pubmed
pubmed-article:11068592pubmed:pagination466-71lld:pubmed
pubmed-article:11068592pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:meshHeadingpubmed-meshheading:11068592...lld:pubmed
pubmed-article:11068592pubmed:year2000lld:pubmed
pubmed-article:11068592pubmed:articleTitle[The time factor in oncology: does the overall treatment time in chemotherapy have a role?].lld:pubmed
pubmed-article:11068592pubmed:affiliationInnere Medizin I, Universitätskliniken des Saarlandes, Homburg/Saar. inltru@med-rz.uni-sb.delld:pubmed
pubmed-article:11068592pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11068592pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11068592pubmed:publicationTypeReviewlld:pubmed